NA Radiopharmaceuticals Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	235 Pages	Data Bridge Market Research	June, 2023	DAABD18055238

Best Price Guarantee
Price	from $3,500
Length	235 Pages
Publisher	Data Bridge Market Research
Published Date	June, 2023
SKU	DAABD18055238

NA Radiopharmaceuticals Market - Industry Trends and Forecast to 2030

The North America radiopharmaceuticals market is expected to reach USD 5,990.71 million by 2030 from USD 3,217.18 million in 2022, growing at a CAGR of 8.1% during the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation
North America Radiopharmaceuticals Market, By Type (Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals), Application (Diagnostic and Therapeutic), Source (Nuclear reactors and Cyclotrons), End User (Hospitals, Diagnostic Centers, Cancer research institutes, Ambulatory surgical centers, and Others), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of North America Radiopharmaceuticals Market Dynamics

Driver
• Growing demand for radiopharmaceutical in diagnostics and clinical use

Restraint

• Potential risks associated with radiopharmaceuticals

Opportunity

• Rising research and development expenditure on radiopharmaceuticals

Market Players

Some of the major market players operating in the North America radiopharmaceuticals market are:

• Cardinal Health
• Advanced Accelerator Applications, A Novartis Company
• Lantheus
• Curium Inc
• GENERAL ELECTRIC COMPANY
• Jubliant Radiopharma, A Jubilant Pharma Company
• China lsotope & Radiation Corporation
• Bracco
• NTP
• Eckert & Ziegler
• SHINE Technologies, LLC
• Eczacıbaşı-Monrol
• IBA Worldwide
• Global Medical Solutions
• BWX Technologies. Inc
• Institute of Isotopes
• Coqui Radiopharmaceuticals Corp,
• Evergreen Theragnostics, Inc.
• Isotope JSC
• PharmaLogic Holdings Corp
• Siemens Healthcare GmBH

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Radiopharmaceuticals Market; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Product Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Market Testing Type Coverage Grid; 2.11 Vendor Share Analysis; 2.12 Secondary Sources; 2.13 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’s Five Forces; 4.3 Pipeline Analysis; 4.4 Patent Analysis; 4.5 Drug Treatment Rate By Matured Markets; 4.6 Demographic Trends: Impacts On All Incidence Rates; 4.7 Patient Flow Diagram; 4.8 Key Pricing Strategies; 4.9 Key Patient Enrollment Strategies
5 List Of Cyclotrons: 5.1 North America
6 Regulatory Scenario: 6.1 North America
7 Market Overview: 7.1 Drivers; 7.1.1 The Growing Demand For Radiopharmaceuticals In Diagnostics And Clinical Use; 7.1.2 The Increasing Need For Pharmaceutical Products Across Varied Therapeutic Areas; 7.1.3 The Increasing Prevalence Of Chronic Diseases; 7.2 Restraints; 7.2.1 Stringent Regulations For Radiopharmaceuticals; 7.2.2 Potential Risks Associated With Radiopharmaceuticals; 7.3 Opportunities; 7.3.1 The Rising Research And Development Expenditure Of Radiopharmaceuticals; 7.3.2 The Growing Incidences Of Complex Diseases In Geriatric Population; 7.4 Challenges; 7.4.1 High Cost Of Development And Implementation Of Radiopharmaceuticals; 7.4.2 Lack Of Technical Expertise And High Cost For Training Existing Workforce
8 North America Radiopharmaceuticals Market, By Type: 8.1 Overview; 8.2 Diagnostic Radiopharmaceuticals; 8.2.1 Pet Radiopharmaceuticals; 8.2.1.1 F-18; 8.2.1.2 Ru-82; 8.2.1.3 Other Pet Isotopes Radiopharmaceuticals; 8.2.2 Spect Radiopharmaceuticals; 8.2.2.1 Technetium-99m; 8.2.2.2 Gallium-67; 8.2.2.3 Iodine-123; 8.2.2.4 Thallium-201; 8.2.2.5 Other Spect Isotopes; 8.3 Therapeutic Radiopharmaceuticals; 8.3.1 Brachytherapy Isotopes; 8.3.1.1 Iodine-125; 8.3.1.2 Palladium-103; 8.3.1.3 Cesium-131; 8.3.1.4 Iridium-192; 8.3.1.5 Other Brachytherapy Isotopes; 8.3.2 Beta Emitters; 8.3.2.1 Iodine-131; 8.3.2.2 Luthetium-177; 8.3.2.3 Samarium-153; 8.3.2.4 Yttrium-90; 8.3.2.5 Rhenium-186; 8.3.2.6 Other Beta Emitters; 8.3.3 Alpha Emitters; 8.3.3.1 Ra-223; 8.3.3.2 Others
9 North America Radiopharmaceuticals Market, By Application: 9.1 Overview; 9.2 Diagnostic; 9.2.1 Pet; 9.2.1.1 Oncology; 9.2.1.2 Cardiology; 9.2.1.3 Neurology; 9.2.1.4 Other Pet Application; 9.2.2 Spect; 9.2.2.1 Cardiology; 9.2.2.2 Bone Scans; 9.2.2.3 Thyroid Applications; 9.2.2.4 Pulmonary Scans; 9.2.2.5 Other Spect Application; 9.3 Therapeutic; 9.3.1 Thyroid Indications; 9.3.2 Bone Metastasis; 9.3.3 Lymphoma; 9.3.4 Endocrine Tumors; 9.3.5 Other Indications
10 North America Radiopharmaceuticals Market, By Source: 10.1 Overview; 10.2 Nuclear Reactors; 10.3 Cyclotrons
11 North America Radiopharmaceuticals Market, By End User: 11.1 Overview; 11.2 Hospitals; 11.3 Diagnostic Centers; 11.4 Cancer Research Institutes; 11.5 Ambulatory Surgical Centers; 11.6 Others
12 North America Radiopharmaceuticals Market, By Region: 12.1 North America; 12.1.1 U.S.; 12.1.2 Canada; 12.1.3 Mexico
13 North America Radiopharmaceuticals Market: Company Landscape: 13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profile: 15.1 Cardinal Health; 15.1.1 Company Snapshot; 15.1.2 Revenue Analysis; 15.1.3 Company Share Analysis; 15.1.4 Product Portfolio; 15.1.5 Recent Development; 15.2 Advanced Accelerator Applications, A Novartis Company; 15.2.1 Company Snapshot; 15.2.2 Revenue Analysis; 15.2.3 Company Share Analysis; 15.2.4 Product Portfolio; 15.2.5 Recent Development; 15.3 Lantheus; 15.3.1 Company Snapshot; 15.3.2 Revenue Analysis; 15.3.3 Company Share Analysis; 15.3.4 Product Portfolio; 15.3.5 Recent Development; 15.4 Curium; 15.4.1 Company Snapshot; 15.4.2 Company Share Analysis; 15.4.3 Product Portfolio; 15.4.4 Recent Development; 15.5 General Electric Company; 15.5.1 Company Snapshot; 15.5.2 Revenue Analysis; 15.5.3 Company Share Analysis; 15.5.4 Product Portfolio; 15.5.5 Recent Development; 15.6 Bracco; 15.6.1 Company Snapshot; 15.6.2 Product Portfolio; 15.6.3 Recent Development; 15.7 Bwx Technologies. Inc.; 15.7.1 Company Snapshot; 15.7.2 Revenue Analysis; 15.7.3 Product Portfolio; 15.7.4 Recent Development; 15.8 China Isotope & Radiation Corporation; 15.8.1 Company Snapshot; 15.8.2 Revenue Analysis; 15.8.3 Product Portfolio; 15.8.4 Recent Development; 15.9 Coqui Radiopharmaceuticals Corp.; 15.9.1 Company Snapshot; 15.9.2 Product Portfolio; 15.9.3 Recent Development; 15.10 Eckert & Ziegler; 15.10.1 Company Snapshot; 15.10.2 Revenue Analysis; 15.10.3 Product Portfolio; 15.10.4 Recent Development; 15.11 Eczacibaşi-monrol; 15.11.1 Company Snapshot; 15.11.2 Product Portfolio; 15.11.3 Recent Development; 15.12 Evergreen Theragnostics, Inc.; 15.12.1 Company Snapshot; 15.12.2 Product Portfolio; 15.12.3 Recent Development; 15.13 North America Medical Solutions; 15.13.1 Company Snapshot; 15.13.2 Product Portfolio; 15.13.3 Recent Development; 15.14 Iba Worldwide; 15.14.1 Company Snapshot; 15.14.2 Revenue Analysis; 15.14.3 Product Portfolio; 15.14.4 Recent Development; 15.15 Institute Of Isotopes; 15.15.1 Company Snapshot; 15.15.2 Product Portfolio; 15.15.3 Recent Development; 15.16 Isotope Jsc; 15.16.1 Company Snapshot; 15.16.2 Product Portfolio; 15.16.3 Recent Development; 15.17 Jubilant Radiopharma A Jubilant Pharmova Company; 15.17.1 Company Snapshot; 15.17.2 Revenue Analysis; 15.17.3 Product Portfolio; 15.17.4 Recent Development; 15.18 Ntp; 15.18.1 Company Snapshot; 15.18.2 Product Portfolio; 15.18.3 Recent Development; 15.19 Pharmalogic Holdings Corp; 15.19.1 Company Snapshot; 15.19.2 Product Portfolio; 15.19.3 Recent Development; 15.20 Shine Technologies, Llc; 15.20.1 Company Snapshot; 15.20.2 Product Portfolio; 15.20.3 Recent Development; 15.21 Siemens Healthcare Gmbh; 15.21.1 Company Snapshot; 15.21.2 Revenue Analysis; 15.21.3 Product Portfolio; 15.21.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables: Table 1 North America Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 2 North America Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 3 North America Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 4 North America Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 5 North America Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 6 North America Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 7 North America Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 8 North America Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 9 North America Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 10 North America Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 11 North America Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 12 North America Diagnostic In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 13 North America Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 14 North America Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 15 North America Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 16 North America Therapeutic In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 17 North America Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 18 North America Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million); Table 19 North America Nuclear Reactors In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 20 North America Cyclotrons In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 21 North America Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million); Table 22 North America Hospitals In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 23 North America Diagnostic Centers In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 24 North America Cancer Research Institutes In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 25 North America Ambulatory Surgical Centers In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 26 North America Others In Radiopharmaceuticals Market, By Region, 2021-2030 (Usd Million); Table 27 North America Radiopharmaceuticals Market, By Country, 2021-2030 (Usd Million); Table 28 North America Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 29 North America Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 30 North America Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 31 North America Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 32 North America Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 33 North America Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 34 North America Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 35 North America Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 36 North America Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 37 North America Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 38 North America Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 39 North America Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 40 North America Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 41 North America Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 42 North America Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 43 North America Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 44 North America Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 45 North America Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 46 North America Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 47 North America Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 48 North America Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 49 North America Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 50 North America Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 51 North America Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million); Table 52 North America Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million); Table 53 U.S. Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 54 U.S. Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 55 U.S. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 56 U.S. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 57 U.S. Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 58 U.S. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 59 U.S. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 60 U.S. Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 61 U.S. Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 62 U.S. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 63 U.S. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 64 U.S. Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 65 U.S. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 66 U.S. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 67 U.S. Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 68 U.S. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 69 U.S. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 70 U.S. Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 71 U.S. Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 72 U.S. Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 73 U.S. Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 74 U.S. Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 75 U.S. Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 76 U.S. Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million); Table 77 U.S. Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million); Table 78 Canada Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 79 Canada Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 80 Canada Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 81 Canada Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 82 Canada Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 83 Canada Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 84 Canada Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 85 Canada Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 86 Canada Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 87 Canada Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 88 Canada Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 89 Canada Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 90 Canada Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 91 Canada Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 92 Canada Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 93 Canada Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 94 Canada Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 95 Canada Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 96 Canada Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 97 Canada Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 98 Canada Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 99 Canada Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 100 Canada Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 101 Canada Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million); Table 102 Canada Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million); Table 103 Mexico Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 104 Mexico Diagnostic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 105 Mexico Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 106 Mexico Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 107 Mexico Pet Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 108 Mexico Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 109 Mexico Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 110 Mexico Spect Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 111 Mexico Therapeutic Radiopharmaceuticals In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 112 Mexico Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 113 Mexico Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 114 Mexico Brachytherapy Isotopes In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 115 Mexico Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 116 Mexico Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 117 Mexico Beta Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 118 Mexico Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Usd Million); Table 119 Mexico Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Volume In Mbq); Table 120 Mexico Alpha Emitters In Radiopharmaceuticals Market, By Type, 2021-2030 (Asp Per Mbq); Table 121 Mexico Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 122 Mexico Diagnostic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 123 Mexico Pet In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 124 Mexico Spect In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 125 Mexico Therapeutic In Radiopharmaceuticals Market, By Application, 2021-2030 (Usd Million); Table 126 Mexico Radiopharmaceuticals Market, By Source, 2021-2030 (Usd Million); Table 127 Mexico Radiopharmaceuticals Market, By End User, 2021-2030 (Usd Million)
List Of Figures: Figure 1 North America Radiopharmaceuticals: Segmentation; Figure 2 North America Radiopharmaceuticals Market: Data Triangulation; Figure 3 North America Radiopharmaceuticals Market: Droc Analysis; Figure 4 North America Radiopharmaceuticals Market: North America Vs Regional Market Analysis; Figure 5 North America Radiopharmaceuticals Market: Company Research Analysis; Figure 6 North America Radiopharmaceuticals Market: Interview Demographics; Figure 7 North America Radiopharmaceuticals Market: Dbmr Market Position Grid; Figure 8 North America Radiopharmaceuticals Market: Market Testing Type Coverage Grid; Figure 9 North America Radiopharmaceuticals Market: Vendor Share Analysis; Figure 10 North America Radiopharmaceuticals Market: Segmentation; Figure 11 The Rising Prevalence Of Chronic Diseases Is Expected To Drive The North America Radiopharmaceuticals Market In The Forecast Period; Figure 12 The Type Segment Is Expected To Account For The Largest Share Of The North America Radiopharmaceuticals Market In 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Radiopharmaceuticals Market; Figure 14 North America Radiopharmaceuticals Market: By Type, 2022; Figure 15 North America Radiopharmaceuticals Market: By Type, 2023-2030 (Usd Million); Figure 16 North America Radiopharmaceuticals Market: By Type, Cagr (2023-2030); Figure 17 North America Radiopharmaceuticals Market: By Type, Lifeline Curve; Figure 18 North America Radiopharmaceuticals Market: By Application, 2022; Figure 19 North America Radiopharmaceuticals Market: By Application, 2023-2030 (Usd Million); Figure 20 North America Radiopharmaceuticals Market: By Application, Cagr (2023-2030); Figure 21 North America Radiopharmaceuticals Market: By Application, Lifeline Curve; Figure 22 North America Radiopharmaceuticals Market: By Source, 2022; Figure 23 North America Radiopharmaceuticals Market: By Source, 2023-2030 (Usd Million); Figure 24 North America Radiopharmaceuticals Market: By Source, Cagr (2023-2030); Figure 25 North America Radiopharmaceuticals Market: By Source, Lifeline Curve; Figure 26 North America Radiopharmaceuticals Market: By End User, 2022; Figure 27 North America Radiopharmaceuticals Market: By End User, 2023-2030 (Usd Million); Figure 28 North America Radiopharmaceuticals Market: By End User, Cagr (2023-2030); Figure 29 North America Radiopharmaceuticals Market: By End User, Lifeline Curve; Figure 30 North America Radiopharmaceuticals Market: Snapshot (2022); Figure 31 North America Radiopharmaceuticals Market: By Country (2022); Figure 32 North America Radiopharmaceuticals Market: By Country (2023 & 2030); Figure 33 North America Radiopharmaceuticals Market: By Country (2022 & 2030); Figure 34 North America Radiopharmaceuticals Market: By Type (2023-2030); Figure 35 North America Radiopharmaceuticals Market: Company Share 2022 (%) 145